The fight against cancer is complex. It’s global. And it’s indisputably expensive.Â
The Mark Foundation for Cancer Research awarded five new Emerging Leader Awards, totaling $3.75 million, to early-career investigators for projects aimed at addressing unmet needs in cancer research.
The Mark Foundation for Cancer Research has announced 16 outstanding projects in its latest class of ASPIRE awards, granting more than $5 million for research that aims to answer key feasibility and proof-of-concept questions in an accelerated time frame, and scaling for impact based upon initial success.Â
The Mark Foundation for Cancer Research announced the recipients of its 2023 Endeavor Award program, providing a total of $12 million across seven institutions to support teams of scientists tackling a range of urgent challenges in the prevention, diagnosis, and treatment of cancer.Â
The Mark Foundation for Cancer Research granted ASPIRE awards of twelve research projects from academic institutions in Germany, Israel, Netherlands, Spain, and USA, totaling more than $4 million.
The Mark Foundation for Cancer Research has given two new Drug Discovery Awards.Â
The Mark Foundation for Cancer Research awarded six new Emerging Leader Awards, totaling $4.5 million, to early-career investigators for projects aimed at addressing unmet needs in cancer research.Â
The Mark Foundation for Cancer Research has awarded eight research projects in six countries with a total of $2.029 million ASPIRE grants.Â
Ryan Schoenfeld was named chief executive officer of The Mark Foundation for Cancer Research. Schoenfeld will oversee the foundation’s scientific programs, investments, and operations, and will be responsible for shaping how The Mark Foundation allocates the $500 million in additional funding recently committed by its founder (The Cancer Letter, Feb. 18, 2022).
The Mark Foundation for Cancer Research selected four scientific research projects to receive $12 million in funding for its 2022 Endeavor Awards.Â
